What is AISAP?
Based in Tel Aviv, Israel, AISAP is at the forefront of developing AI-powered diagnostic tools designed for point-of-care applications. The company's solutions aim to enhance diagnostic accuracy and efficiency directly at the patient's location, potentially revolutionizing how medical professionals approach preliminary assessments and diagnoses. This focus on accessible, AI-assisted diagnostics positions AISAP as a key player in the digital health and medical AI landscape.
How much funding has AISAP raised?
AISAP has raised a total of $1.3M across 1 funding round:
Angel/Seed
$1.3M
Angel/Seed (2024): $1.3M with participation from Harel Insurance Investments & Financial Services
Key Investors in AISAP
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services LTD. is one of Israel's largest insurance and finance groups, providing comprehensive financial and insurance solutions. Their investment in AISAP suggests a strategic interest in the burgeoning field of health technology and AI-driven medical diagnostics.
What's next for AISAP?
The recent major strategic investment signals a pivotal moment for AISAP, likely enabling the company to accelerate its product development, expand its market reach, and further refine its AI algorithms. With a substantial total funding amount, AISAP is well-positioned for significant growth and scaling its operations. Future endeavors may include forging new partnerships, enhancing its technological capabilities, and navigating the complex regulatory pathways inherent in the medical device and AI sectors.
See full AISAP company page
